[CLSTR]
< Back to situations

[ORGANIZATION]

Mochi Health

Featured in 2 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

276 clusters · 1039 sources · last updated

Latest: Eli Lilly's retatrutide shows significant weight loss in Phase 3 trials

Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr

Also covered in